|
|
|
|
|
|
|
|
| |
| |
|
|
 |
|
 |
|
|
|
| |
| THE KINASE PROMISE . . . |
 |
|
| Xcovery is a new biotech company spun out from
The Scripps Research Institute by Sherry Snyder (CEO) and Chris
Liang (CSO), with the support of several prominent academic partners.
Mr. Snyder is the founder and former CEO of Genzyme – one
of the world’s most successful biotech companies, as well
as kinase company Upstate Biotechnology (since sold to Serologicals.)
Dr. Liang is a co-inventor of Sutent, Pfizer’s lead cancer
drug, and currently Director of Medicinal Chemistry the Scripps
Research Institute in Jupiter, Florida. |
|
| Xcovery will develop next generation kinase
therapeutics for cancer and inflammatory diseases. Xcovery’s
approach, based on Dr. Liang’s ten years of kinase medicinal
chemistry experience generates lead compounds with greater selectivity
and efficacy and reduced toxicity more rapidly and economically
than current approaches. |
|
| Xcovery best-in-class therapeutics will be partnered
with leading biotech and pharmaceutical partners, and for self-development. |
| |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
